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Abstract
Cell-culture methods that simplify the inherent complexities of the kidney have not suffi-
ciently reproduced its true characteristics. Although reports indicate that organoid methodol-
ogy surpasses traditional cell culture in terms of reproducing the nature of organs, the study
of human kidney organoids have been confined to pluripotent stem cells. Furthermore, it
has not yet progressed beyond the developmental state of embryonic kidney even after
complicate additional differentiation processes. We here describe the kidney organotypic
culture method that uses adult whole kidney tissues but mainly differentiates into tubular
cells. This model was validated based on the retention of key kidney organotypic-specific
features: 1) expression of Tamm-Horsfall protein; 2) dome-like organoid configurations,
implying directed transport of solutes and water influx; and 3) organoid expression of neutro-
phil gelatinase-associated lipocalin (NGAL) and kidney injury molecule-1 (KIM-1) in
response to nephrotoxic injury (i.e., gentamicin and cisplatin exposure). This 3D-structured
organoid prototype of the human renal tubule may have applications in developing patient-
specific treatments for kidney diseases.
Introduction
The global prevalence of chronic kidney disease is 13.4%, which represents a major cost bur-
den to healthcare systems worldwide [1]. At present, patient management remains limited to
reducing inflammation, optimizing cardiovascular risk, and providing supportive care. A bet-
ter understanding of physiologic and pathophysiologic mechanisms involved in renal damage
and repair will likely promote therapeutic advancements [2].
The human kidney harbors a number of cell types, and its architecture is complex, posing a
challenge for in vivo studies. Although two-dimensional (2D) cell-culture models have value in
the study of renal pathophysiology, the superiority of three-dimensional (3D) culture models
that simulate the in vivo environment is readily acknowledged [2]. Therefore, an effective
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organoid model that mimics the human kidney is a welcomed contribution. Organoids reflect
key structural and functional properties of bodily organs, providing a potential means of repli-
cating human organ pathologies “in a dish” [3].
Such 3D organoids have been derived from tissue-specific progenitors, induced pluripotent
stem cells (iPSCs), or embryonic stem cells (ESCs) to mimic a host or human organs, including
brain [4], retina [5], stomach [6], small intestine [6], lung [7], thyroid [8], liver [9], pancreas
[10], and kidney [11]; and their features are distinctive. Organoid models incorporate multiple
organ-specific cell types, recapitulating organ development and function. They also self-
organize through cell sorting and spatially restricted lineage commitment in manners similar
to in vivo events [12]. The therapeutic ramifications of organoid technology extend to infec-
tious disease [13], hereditary disorders [4], drug-related toxicity [14], tumorogenesis [15], and
organ transplantation [16]. With personalized medicine as the goal, identifying and imple-
menting successful patient treatments seem feasible [3].
Although the vast potential of organoids is abundantly clear, one must bear in mind the
current constraints. They lack innervation, vascularization, and immune cells, so diseases
states under study are incompletely reproduced [3]. Furthermore, the use of human ESCs
raises ethical concerns, and the clinical utility of iPSC-derived organoids is undermined by
tumorigenic risk [17]. Resolution of these issues no doubt would heighten the use of organoids
in research fields and clinics [17, 18]. Indeed, such problems could be circumvented by using
normal human kidney cells for organoid experimentation, which to our knowledge has yet to
be pursued.
Stem cell organoids consume substantial amounts of time and funding due to the many
growth factors needed and various differentiation stages that must occur. Even so, these stud-
ies have yielded nothing more than progenitor kidney, and experimental models of this nature
are far removed from clinical practice. The present investigation was undertaken to generate
an efficient organoid model from adult human kidney tissue. Ultimately, expression of kid-
ney-specific proteins and replication of 3D tubular structure by organoid constituents were
used for validation.
Materials and methods
Human tissues and primary tubule cells
Normal renal tissues were collected from patients who provided informed consent as stipu-
lated by the Yonsei University Health System, Severance Hospital, Institutional Review Board,
and the study protocol was approved by the same institutional review board (approval number
4-2015-0104). Primary normal human RPTECs were purchased from the American Type Cul-
ture Collection (ATCC, PCS-400-010) and were maintained (37˚C, 5% CO2) in renal epithelial
cell growth media (ATCC, PCS-400-040) containing 0.5% fetal bovine serum (FBS), 10 nM tri-
iodothyronine, 10 ng/ml recombinant human EGF, 100 ng/ml hydrocortisone, 5 μg/ml recom-
binant human insulin, 1 μM epinephrine, 5 μg/ml transferrin, and 2.4 mM L-alanyl-L-
glutamine.
Organotypic culture
Using a blade, dissected human kidney samples were minced into 1 × 1-mm pieces, then incu-
bated (37˚C, 2 h) in 5 ml of Dulbecco’s Modified Eagle Medium/Nutrient Mixture F-12
(DMEM-F12; Gibco [Thermo Fisher], Grand Island, NY, USA), supplemented with 1% FBS,
3 mg/ml collagenase type II (Sigma-Aldrich, St Louis, MO, USA), and 1× antibiotic/antimyco-
tic solution (Sigma-Aldrich) to allow for tissue dissociation/degradation. Thereafter, the prod-
uct was triturated vigorously by pipetting (1 min) and filtering through a 70-μm cell strainer
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(Corning Corp, Corning, NY, USA). Cell pellets from subsequent centrifugation (~200 g, 2
min) were gently washed twice in phosphate-buffered saline (PBS). We used two methods to
culture kidney organoids: the membrane matrix (Matrigel; Corning Inc, Corning, NY, USA)
3D-embedded method and the 3D-on-top assay, a more cost-effective alternative [19]. Briefly,
1–2 ml of Matrigel (Corning) was added to each cell pellet (approximately 1x103 cells/μl of
matrigel) within a 6-well culture plate (3D embedded) in an organoid substrate of serum-free
keratinocyte medium (Gibco) supplemented with 10 ng/ml recombinant human EGF (Gibco),
50 μg/ml bovine pituitary extract (Gibco), 0.01 mg/ml recombinant human insulin, 55 μg/ml
human transferrin (substantially iron-free), 5 ng/ml sodium selenite (ITS supplement, Sigma),
500 nM hydrocortisone (Sigma), 100 ng/ml human recombinant Noggin (PeproTech, Rocky
Hill, NJ, USA), 10 nM Leucin (Sigma), 5 μM Y-27632 (Enzo Life Sciences, Farmingdale, NY,
USA), and 5% FBS. For 3D-on-top culture, cells were plated on Matrigel (freshly molded)
within organoid culture medium in a 6-well plate. For serial passage of organoids (every 1–2
weeks), incubation (37˚ C, 5 min) in a 1:4 dilution of 0.25% trypsin was used, followed by
mechanical dissociation to nearly single-cell suspensions (as described by Chua et al) [20].
Cell proliferation assay (CCK-8 assay)
Human RPTECs and cells from normal renal tissues were loaded in triplicate in 48-well cul-
ture plate with matrigel (1x104 cells or 3x104 cells/25μl of each matrigel dom). Cells were incu-
bated for 72hr in renal epithelial cell growth media and organoid media, respectively. The cell
proliferation was detected by Cell Counting kit-8 (CCK-8, Dojindo Laboratories, Kumamoto,
Japan). 2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazo-
lium, monosodium salt was added each well and incubated for 1hr. A water soluble formazan
product in media was determined using a Beckman Coulter microplate reader at 450nm.
Immunofluorescent preparations
Expression levels of Tamm-Horsfall protein (THP), pan-keratin (Ker), NGAL, and KIM-1
were measured using immunofluorescence. Briefly, after a 2-week differentiation period, 3D
kidney organoids (3D-embedded) in PBS were pipetted very gently to separate them from the
Matrigel matrix for whole organoid stain. Whole organoids seeded (37˚C, 16 h) onto an
8-chamber cell-culture slide were fixed (10 min) in 4% paraformaldehyde solution and washed
in PBS. Cells were permeated (5 min) in 0.5% Triton X-100/PBS, blocked (20 min) with 5%
BSA/PBS, and incubated (4˚C, 16 h) in diluted primary antibodies: FITC-conjugated anti-
THP (Cedarlane Laboratories, Burlington, NC, USA), anti-NGAL (Abcam, Cambridge, UK),
anti-KIM-1 (Abcam) and anti-pan-keratin (Cell Signaling Technology, Danvers, MA, USA).
Finally, PBS-washed cells were exposed (25˚ C, 1 h) to secondary antibodies tagged with Alexa
Fluor 488 or 594 (1:200; Invitrogen [Thermo Fisher], Waltham, MA, USA). Images were cap-
tured using a confocal microscope (LSM 700 META; Carl Zeiss AG, Oberkochen, Germany)
and analyzed using proprietary software (LSM Image Browser).
Acute nephrotoxic injury model
To induce injury, 3D kidney organoids differentiated for 2 weeks (3D-embedded) were incu-
bated (24 h) in 2 mg/ml gentamicin (Sigma) or 5 μM cisplatin (Sigma) and transferred by spat-
ula to 1% agarose in DMEM for immobilization (room temperature, 30 min). Subsequently,
cells were fixed in 10% formalin (room temperature, 24 h) for routine histologic processing,
paraffin embedding, and sectioning. Upon deparaffinization, morphology was confirmed
microscopically by hematoxylin and eosin staining, and expression levels of NGAL and KIM-
Kidney organotypic culture
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1, determined by immunofluorescent staining, were used as markers to gauge acute nephro-
toxic injury.
Statistical analysis
Quantitative values were expressed as mean ± standard deviation (SD). Statistical differences
were compared via Mann-Whitney U-test, using standard software (IBM SPSS Statistics v23.0;
IBM Corp, Armonk, NY, USA) for all computations. A p<0.05 was considered statistically
significant.
Results
Normal human kidney cells form tubulocysts in 3D culture
Normal human kidney cells exhibited morphologic characteristics similar to primary renal
proximal tubular epithelial cells (RPTECs) (ATCC, PCS-400-010), forming tight epithelial lay-
ers when grown to confluency in 2D culture (Fig 1A). They also assumed dome-like tubulocys-
tic configurations (called tubulocysts) in 3D culture and 3D-on-top culture (Fig 1B). The 3D-
on-top culture was used for cleaner colonies images of human kidney tubular organoids and
easy handling with Matrigel than the 3D-embedded assay (Fig 1B) [19].
Normal human kidney cells generate more tubulocysts than primary renal
proximal tubular epithelial cells (RPTECs) (ATCC, PCS-400-010) in
organoid culture
Both primary RPTECs and normal human kidney cells formed tubulocysts in organoid cul-
tures (Fig 2A). Tubulocysts counts in human kidney tubular organoids exceeded those of pri-
mary RPTEC organoids. When each tubulocyst was categorized by size (diameter), the counts
in human kidney tubular organoids greatly surpassing those of primary RPTEC organoids for
all categories (�170 μm, p = 0.043; 100–170 μm, p = 0.050; 50–100 μm, p = 0.046) (Fig 2B).
Cell proliferation was also more prominent in human kidney cells compared to RPTEC cells.
When the same number of cells (1x104 cells and 3x104 cells/25μl) were loaded, after 72hrs the
human kidney cells proliferated 1.4 and 2.6- fold more, respectively, compared to RPTEC cells
(Fig 2C).
Normal human kidney cells express Tamm-Horsfall protein, acquiring
morphologic features of renal tubular cells
Normal human kidney cells in 2D or 3D culture expressed Tamm-Horsfall protein, an event
typical of renal tubules (Fig 3A) [21, 22]. Tamm-Horsfall protein expression was greater in 3D
(vs 2D) cultures of normal human kidney cells (p = 0.009) (Fig 3A). These results highlight the
relative superiority of 3D culture in simulating one aspect of renal tubules. In addition, the
normal human kidney cells formed dome-like structures with central lumens when grown in
Matrigel. In these distinctly tubular organoids, expression of Tamm-Horsfall protein was
robust (Fig 3B and S1 Video).
Validation of experimental organoids derived from normal human kidney
cells
Acute renal injury results from damage to renal tubular cells due to frequent exposure to neph-
rotoxic substances, such as gentamicin and cisplatin. Neutrophil gelatinase-associated lipocalin
(NGAL) and kidney injury molecule-1 (KIM-1), specific biomarkers for tubular injury [23],
Kidney organotypic culture
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were higher in normal human kidney cells treated with nephrotoxic drugs, compared with
controls (Fig 4 and S1 Fig). Slides of human kidney tubular organoids selectively exposed to
cisplatin were stained with hematoxylin and eosin (Fig 4A). The integrity of cisplatin-treated
tubular organoids was disrupted compared with untreated organoids (Fig 4A). Expression lev-
els of KIM-1 and NGAL were investigated in human kidney tubular organoids, both with and
without cisplatin exposure (Fig 4B and 4C). Both markers had significantly higher expression
levels (p = 0.016 and p = 0.028, respectively) in cisplatin-treated organoids than in controls
(Fig 4D).
NGAL expression was also evaluated in gentamicin- and cisplatin-treated human kidney
tubular organoids (S1A Fig). The cisplatin-treated organoids showed significantly higher
Fig 1. Primary renal proximal tubular epithelial cells (RPTECs) and normal human kidney cells form tubulocysts. (A) Phase-contrast images:
primary RPTECs and normal human kidney cells showing similar cellular morphologies in 2D cultures. (B) Phase-contrast images: spherule formation
observed in primary RPTECs and normal human kidney cells. The 3D-on-top assay provides a clearer image of human normal kidney cell organoids
than the 3D-embedded assay.
https://doi.org/10.1371/journal.pone.0206447.g001
Kidney organotypic culture
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NGAL expression compared with controls (p = 0.004) (S1A Fig). Gentamicin-treated orga-
noids showed higher NGAL expression than controls, but the difference was not statistically
significant (p = 0.078) (S1A Fig). KIM-1 expression in gentamicin-treated organoids and con-
trols was similar (S1B Fig). In aggregate, these findings indicate that experimental organoid
models of normal human kidney cells respond to nephrotoxic substances in a manner similar
to that of normal human kidney tubular cells.
Discussion
The kidney is an architecturally complex organ composed of many cell types and not easily
studied in vivo. For this reason, simpler research tools are typically used, particularly 2D cul-
ture models. Several studies have generated intermediate mesoderm from pluripotent stem
cells (i.e., ESCs, induced pluripotent stem cells) that can be used to reconstitute kidney [24,
25]. However, these organoids like nephron progenitors cannot accurately model the
Fig 2. Normal human kidney cells generate more tubulocysts than primary renal proximal tubular epithelial cells (RPTECs). (A) Phase-contrast
images: primary RPTECs and normal human kidney cells exhibiting tubulocysts formation. (B) Quantification (counts) of tubulocysts in primary
RPTEC and normal human kidney cell organoids, categorized by size. Results expressed as mean (± SD) of three independent experiments (n = 3);
�p<0.05 vs control. (C) Proliferation assay of primary RPTECs and normal human kidney cells using CCK8 for 72hr. Each matrigel dome containing
1x104 cells and 3x104 cells/25μl of matrigel were loaded in 48-well culture plates. All experiments were performed in triplicate for each condition and
repeated at least twice. �p<0.05 vs control.
https://doi.org/10.1371/journal.pone.0206447.g002
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complexity of the kidney. While 2D cell-culture models are valuable for the study of renal
pathophysiology, 3D-culture models are now considered superior because they can produce a
biomimetic environment [2]. Unlike 2D cultures, the more complex tissue elements of 3D cul-
tures have advanced self-organization and enhanced structural capacities [11]. The resem-
blance of organoids to human kidney imparts greater value as a model. Recently, several
researchers have generated kidney organoids (ureteric bud, metanephric mesenchyme, or
both) from pluripotent stem cells (embryonic or induced) [11, 26, 27]. The key structural and
functional properties of organs replicated through organoid technology may prove useful for
exploring human organ pathologies “in a dish” [3].
The value of any cell culture as a disease model or as a target of cell therapy or transplanta-
tion depends upon normal genetic/epigenetic sustainability [28]. In terms of safety, the tumor-
igenic risk of induced pluripotent stem cells limits their clinical use [17], and usage of human
ESCs raises ethical concerns. In addition, organoids derived from pluripotent stem cells (vs
adult cells) have two distinct drawbacks: 1) time and cost inefficiencies and 2) no assurance of
cellular lineage. The adult-cell organoid model we devised circumvents these issues and offers
a viable research alternative. To date, organoids have been generated from adult stem cells of
Fig 3. Human kidney tubular organoid expression of kidney-specific molecules and formation of dome-like structures. (A) Confocal images:
immunostaining of normal human kidney cells for Tamm-Horsfall protein in 2D and 3D cultures (upper panel); quantification of fluorescence intensity
of Tamm-Horsfall protein expression by normal human normal kidney cells in 2D and 3D cultures (lower panel). THP-FITC (green), FITC-conjugated
anti-Tamm-Horsfall protein; DAPI (blue), 40,6-diamidine-20-phenylindole dihydrochloride. Results expressed as mean (± SD) of five independent
experiments (n = 5); �p< 0.05 vs control. (B) 3D reconstruction of confocal z-stacks: immunostaining of mildly dissolved and re-cultured human kidney
tubular organoids for Tamm-Horsfall protein. THP-FITC (green), FITC-conjugated anti-Tamm-Horsfall protein; pan-keratin (red), anti-pan-keratin
antibody; DAPI (blue), 40,6-diamidine-20-phenylindole dihydrochloride.
https://doi.org/10.1371/journal.pone.0206447.g003
Kidney organotypic culture
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mammary glands [29], bone [30], small intestine [31, 32], stomach [13, 33], colon [34, 35],
liver [36, 37] pancreas [10, 38], lung [39], prostate [40, 41], salivary gland [42] and tongue [43]
but never before from adult kidney cells. Although it is difficult to generate a perfect adult kid-
ney cells derived organoid with a complex structure and individual functions, it is challenging
to produce adult kidney organoids while staying from complicated differentiation process that
require much time and cost like stem cells.
In the present study, the human kidney tubular organotypic model generated from normal
human kidney cells was fully realized and validated. We initially used commercially available
tubular cells (primary RPTECs) as controls to gauge the replication of tubular cells in our orga-
notypic model, comparing respective cellular morphologies (Fig 1A). Our organotypic model
showed a greater variety of cell types, although most were similar to those generated by pri-
mary RPTECs. The morphologies of organoids formed by normal human kidney cells and pri-
mary RPTECs in 3D-embedded culture (Fig 1B), were similar. The same result was observed
using 3D-on-top cultures (Fig 1B), indicating that the methods are comparable. However, 3D-
on-top culture was less demanding than 3D-embedded culture in terms of time, Matrigel use,
and ease of imaging and cell purification.
The normal human kidney cells we obtained from patients were used immediately with all
of the cells that constitute the kidney for 3D organotypic culture from the onset, whereas pri-
mary RPTECs was prepared through the optimal step to acquire pure tubular cells by 2D
Fig 4. Human kidney tubular organoid response to nephrotoxic drugs. (A) Light microscopy: hematoxylin and eosin staining of human kidney
tubular organoid sections, untreated (Control) and cisplatin-treated (Cisplatin). (B, C) Confocal images: immunostaining of kidney injury molecule-1
(KIM-1), neutrophil gelatinase-associated lipocalin (NGAL), and Tamm-Horsfall protein (THP) in untreated (Control) and cisplatin-treated
(Cisplatin) human kidney tubular organoid sections. (D) Quantification of fluorescence intensity of KIM-1 and NGAL in untreated (Control) and
cisplatin-treated (Cisplatin) human kidney tubular organoids. KIM-1 (red), anti-KIM-1 antibody; NGAL (red), anti-NGAL antibody; THP (green),
FITC-conjugated anti-Tamm-Horsfall protein; DAPI (blue), 40,6-diamidine-20-phenylindole dihydrochloride. Results expressed as mean (± SD) of five
independent experiments (n = 5); �p<0.05 vs control.
https://doi.org/10.1371/journal.pone.0206447.g004
Kidney organotypic culture
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culture method. Normal human kidney organotypic model more readily showed the forma-
tion of tubulocysts than primary RPTECs (Fig 2A and 2B). This finding suggests that our 3D
organotypic condition supports more proper kidney cell culture milieu to proliferate and
differentiate.
Organoid 3D-structures have been cultivated previously from pluripotent stem cells, neo-
natal stem cells, and adult stem cells/adult progenitors [44]. To generate human kidney tubular
organoids, epidermal growth factor (EGF), Noggin, and Rho kinase inhibitor were used. Thus,
our organoid model required only an appropriate environment and was unencumbered by
genetic mutations or induction of cellular differentiation. Adult stem cells possess more geno-
mic stability than pluripotent stem cells, and it is genomic stability that confers the greatest
advantage in organoid culture techniques [44].
We also measured the amount of Tamm-Horsfall protein expressed by normal human kid-
ney cells in both 2D culture and organotypic culture. Tamm-Horsfall protein is kidney-specific
and expressed in renal tubules [21]. Compared with 2D culture, organotypic culture showed
greater expression of Tamm-Horsfall protein (Fig 3A), suggesting that human kidney orga-
noids better approximate normal cellular characteristics.
When organoids were dissolved and re-cultured, dome-like structures emerged (Fig 3B and
S1 Video), indicating that solute transport and water influx were occurring in these tubular
formations [45]. The latter is an important function of renal tubular cells, which underscores
the potential to reproduce renal tubular function with human kidney tubular organoids.
Finally, expression levels of KIM-1 and NGAL were assessed after exposing human kidney
tubular organoids to gentamicin or cisplatin (Fig 4 and S1 Fig). Gentamicin and cisplatin are
commonly used for nephrotoxicity screening. The response shown by human kidney tubular
organoids was identical to that documented in the kidneys. Of note, reaction to these particu-
lar nephrotoxic drugs is not universally representative. Further research is needed, using a
broader range of agents. There were several study limitations. First, it is hard to observe other
non-tubular elements (e.g., glomeruli) developed, perhaps because tubules account for the
largest proportion of renal mass. On the other hand, conditions used in this study may simply
have favored the formation of tubular structures. Variations in culture conditions may be
needed to test this hypothesis in future studies.
Another limitation is the drug-induced nephrotoxic injury used for functional validation.
The human kidney is a highly vascularized organ, receiving 25% of the cardiac output. Thus,
the vascular effects of drugs are an important aspect of nephrotoxicity. Some studies have
shown that renal blood flow decreases in kidney damage caused by gentamicin and cisplatin
[46, 47]. Therefore, the lack of a vascular component creates a critical void in our model.
Organoid cultures derived from kidney biopsy samples may be of value in studying the
pathophysiology of renal epithelium. Clearly, there are potential applications for such models
[2]. First, we could use this organotypic technique to determine the mechanisms of renal
homeostasis and role of adult stem cells in kidneys. High-throughput screening of related
genes and factors would allow us to gain a better understanding of renal physiology. Second,
our understanding of the pathophysiology of kidney disease could be broadened. In patients
with genetically linked kidney diseases, the use of organoid renal constructs (biopsy generated)
or genetic engineering tools, such as Zinc-finger nuclease, transcription activator-like effector
nucleases (TALEN), and CRISPR-Cas9 [44], may offer new hope for treatment or a cure. In
fact, the cysts that characterize polycystic kidney disease have been observed in kidney orga-
noids derived from human pluripotent stem cells with CRISPR-Cas9-mutated PKD1 or PKD2
genes [48]. A tissue-based organoid model of renal cell carcinoma is also feasible, and would
shed light on possible new treatments. Studies of kidney-specific infectious diseases such as
polyoma BK virus are also conceivable [49, 50]. Third, a biobank of renal organoids derived
Kidney organotypic culture
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from the general population could be used as a source of tissue for nephrotoxicity studies. In
some respects, organoids are superior to animal models as drug screening tools because they
would eliminating interspecies differences and human heterogeneity. The promise of func-
tional, implantable kidneys represents the pinnacle of organoid potential.
Despite the many imagined uses for organoids, it is important to consider the current limi-
tations. Organoid models are not innervated or vascularized and are devoid of immune cells,
so disease processes are only partially represented [3]. Nevertheless, the kidney-specific gene
expression, 3D configuration, and response to nephrotoxic drugs they display provide a rea-
sonable platform for studies of renal physiology or drug toxicity screening.
Herein, we have successfully cultured human adult kidney tubular organoids through pro-
totypic cultivation of normal human kidney cells. Our organotypic model replicates kidney-
specific features but still needs further development. In this study, we showed that our protocol
of organotypic culture was sufficient to promote organoid formation in kidney tubules. Fur-
ther studies are needed to identify the most suitable conditions for studying kidney physiology,
pathophysiology, drug toxicity, and transplantable tissue. This model is a milestone event,
moving us closer to realizing precise, patient-oriented clinical treatments.
Supporting information
S1 Fig. Human kidney tubular organoid response to nephrotoxic drugs. (A) Confocal
images: immunostaining of neutrophil gelatinase-associated lipocalin (NGAL) in mildly dis-
solved and re-cultured human kidney tubular organoids after gentamicin or cisplatin treat-
ment, compared with untreated controls (upper panel); quantification of fluorescence
intensity of NGAL in gentamicin-treated, cisplatin-treated, or untreated (control) human kid-
ney tubular organoids (lower panel). NGAL (red), anti-NGAL antibody; DAPI (blue), 40,6-dia-
midine-20-phenylindole dihydrochloride. Results expressed as mean (± SD of six independent
experiments (n = 6); �p<0.05 vs control. (B) Confocal images: immunostaining of kidney
injury molecule-1 (KIM-1) and Tamm-Horsfall protein (THP) in human kidney tubular orga-
noid sections. Gentamicin, gentamicin-treated human kidney tubular organoid; KIM-1 (red),
anti-kidney injury molecule-1 antibody; THP (green), anti- Tamm-Horsfall protein (FITC-
conjugated); DAPI (blue), 40,6-diamidine-20-phenylindole dihydrochloride.
(PDF)
S1 Video. Dome-like configuration of human kidney tubular organoid. Confocal 3D-stack
of human kidney tubular organoid, as dipicted in Fig 3B. Human kidney tubular organoid
expression of Tamm-Horsfall protein (green), pan-keratin (red), and DAPI (blue) nuclear
staining.
(AVI)
Acknowledgments
This study was financially supported by a National Research Foundation grant (NRF-
2015R1D1A1A02062166) funded by the Korean government (MEST).
Author Contributions
Conceptualization: Sook Young Kim, Woong Kyu Han.
Data curation: Dae-young Jun, Sook Young Kim.
Formal analysis: Dae-young Jun, Sook Young Kim, Joon Chae Na.
Kidney organotypic culture
PLOS ONE | https://doi.org/10.1371/journal.pone.0206447 October 31, 2018 10 / 13
Methodology: Joon Chae Na, Hyung Ho Lee, Jeehoon Kim, Young Eun Yoon, Sung Joon
Hong.
Writing – original draft: Dae-young Jun.
Writing – review & editing: Sook Young Kim, Woong Kyu Han.
References
1. Hill NR, Fatoba ST, Oke JL, Hirst JA, O’Callaghan CA, Lasserson DS, et al. Global Prevalence of
Chronic Kidney Disease—A Systematic Review and Meta-Analysis. PLoS One. 2016; 11(7):e0158765.
https://doi.org/10.1371/journal.pone.0158765 PMID: 27383068.
2. Rookmaaker MB, Schutgens F, Verhaar MC, Clevers H. Development and application of human adult
stem or progenitor cell organoids. Nat Rev Nephrol. 2015; 11(9):546–54. https://doi.org/10.1038/
nrneph.2015.118 PMID: 26215513.
3. Clevers H. Modeling Development and Disease with Organoids. Cell. 2016; 165(7):1586–97. https://
doi.org/10.1016/j.cell.2016.05.082 PMID: 27315476.
4. Lancaster MA, Renner M, Martin CA, Wenzel D, Bicknell LS, Hurles ME, et al. Cerebral organoids
model human brain development and microcephaly. Nature. 2013; 501(7467):373–9. https://doi.org/10.
1038/nature12517 PMID: 23995685.
5. Eiraku M, Takata N, Ishibashi H, Kawada M, Sakakura E, Okuda S, et al. Self-organizing optic-cup mor-
phogenesis in three-dimensional culture. Nature. 2011; 472(7341):51–6. https://doi.org/10.1038/
nature09941 PMID: 21475194.
6. McCracken KW, Cata EM, Crawford CM, Sinagoga KL, Schumacher M, Rockich BE, et al. Modelling
human development and disease in pluripotent stem-cell-derived gastric organoids. Nature. 2014;
516(7531):400–4. https://doi.org/10.1038/nature13863 PMID: 25363776.
7. Dye BR, Hill DR, Ferguson MA, Tsai YH, Nagy MS, Dyal R, et al. In vitro generation of human pluripo-
tent stem cell derived lung organoids. Elife. 2015; 4. https://doi.org/10.7554/eLife.05098 PMID:
25803487.
8. Longmire TA, Ikonomou L, Hawkins F, Christodoulou C, Cao Y, Jean JC, et al. Efficient derivation of
purified lung and thyroid progenitors from embryonic stem cells. Cell Stem Cell. 2012; 10(4):398–411.
https://doi.org/10.1016/j.stem.2012.01.019 PMID: 22482505.
9. Takebe T, Sekine K, Enomura M, Koike H, Kimura M, Ogaeri T, et al. Vascularized and functional
human liver from an iPSC-derived organ bud transplant. Nature. 2013; 499(7459):481–4. https://doi.
org/10.1038/nature12271 PMID: 23823721.
10. Huch M, Bonfanti P, Boj SF, Sato T, Loomans CJ, van de Wetering M, et al. Unlimited in vitro expansion
of adult bi-potent pancreas progenitors through the Lgr5/R-spondin axis. Embo j. 2013; 32(20):
2708–21. Epub 2013/09/21. https://doi.org/10.1038/emboj.2013.204 PMID: 24045232.
11. Takasato M, Er PX, Becroft M, Vanslambrouck JM, Stanley EG, Elefanty AG, et al. Directing human
embryonic stem cell differentiation towards a renal lineage generates a self-organizing kidney. Nat Cell
Biol. 2014; 16(1):118–26. http://www.nature.com/ncb/journal/v16/n1/abs/ncb2894.
html#supplementary-information. https://doi.org/10.1038/ncb2894 PMID: 24335651
12. Lancaster MA, Knoblich JA. Organogenesis in a dish: modeling development and disease using orga-
noid technologies. Science. 2014; 345(6194):1247125. Epub 2014/07/19. https://doi.org/10.1126/
science.1247125 PMID: 25035496.
13. Bartfeld S, Bayram T, van de Wetering M, Huch M, Begthel H, Kujala P, et al. In Vitro Expansion of
Human Gastric Epithelial Stem Cells and Their Responses to Bacterial Infection. Gastroenterology.
2015; 148(1):126–36.e6. http://dx.doi.org/10.1053/j.gastro.2014.09.042. PMID: 25307862
14. Takasato M, Er PX, Chiu HS, Maier B, Baillie GJ, Ferguson C, et al. Kidney organoids from human iPS
cells contain multiple lineages and model human nephrogenesis. Nature. 2015; 526(7574):564–8.
http://www.nature.com/nature/journal/v526/n7574/abs/nature15695.html#supplementary-information.
https://doi.org/10.1038/nature15695 PMID: 26444236
15. Nadauld LD, Garcia S, Natsoulis G, Bell JM, Miotke L, Hopmans ES, et al. Metastatic tumor evolution
and organoid modeling implicate TGFBR2as a cancer driver in diffuse gastric cancer. Genome Biology.
2014; 15(8):428. https://doi.org/10.1186/s13059-014-0428-9 PMID: 25315765
16. Yui S, Nakamura T, Sato T, Nemoto Y, Mizutani T, Zheng X, et al. Functional engraftment of colon epi-
thelium expanded in vitro from a single adult Lgr5+ stem cell. Nat Med. 2012; 18(4):618–23. http://www.
nature.com/nm/journal/v18/n4/abs/nm.2695.html#supplementary-information. https://doi.org/10.1038/
nm.2695 PMID: 22406745
Kidney organotypic culture
PLOS ONE | https://doi.org/10.1371/journal.pone.0206447 October 31, 2018 11 / 13
17. Knoepfler PS. Deconstructing Stem Cell Tumorigenicity: A Roadmap to Safe Regenerative Medicine.
STEM CELLS. 2009; 27(5):1050–6. https://doi.org/10.1002/stem.37 PMID: 19415771
18. Kaminski MM, Tosic J, Kresbach C, Engel H, Klockenbusch J, Muller A-L, et al. Direct reprogramming
of fibroblasts into renal tubular epithelial cells by defined transcription factors. Nat Cell Biol. 2016;
18(12):1269–80. http://www.nature.com/ncb/journal/v18/n12/abs/ncb3437.html#supplementary-
information. https://doi.org/10.1038/ncb3437 PMID: 27820600
19. Lee GY, Kenny PA, Lee EH, Bissell MJ. Three-dimensional culture models of normal and malignant
breast epithelial cells. Nat Methods. 2007; 4(4):359–65. Epub 2007/03/31. https://doi.org/10.1038/
nmeth1015 PMID: 17396127.
20. Chua CW, Shibata M, Lei M, Toivanen R, Barlow LJ, Bergren SK, et al. Single luminal epithelial progeni-
tors can generate prostate organoids in culture. Nat Cell Biol. 2014; 16(10):951–61, 1–4. Epub 2014/09/
23. https://doi.org/10.1038/ncb3047 PMID: 25241035.
21. Pennica D, Kohr WJ, Kuang WJ, Glaister D, Aggarwal BB, Chen EY, et al. Identification of human uro-
modulin as the Tamm-Horsfall urinary glycoprotein. Science. 1987; 236(4797):83–8. Epub 1987/04/03.
PMID: 3453112.
22. Sikri KL, Foster CL, MacHugh N, Marshall RD. Localization of Tamm-Horsfall glycoprotein in the human
kidney using immuno-fluorescence and immuno-electron microscopical techniques. J Anat. 1981;
132(Pt 4):597–605. Epub 1981/06/01. PMID: 7028707.
23. Schrezenmeier EV, Barasch J, Budde K, Westhoff T, Schmidt-Ott KM. Biomarkers in acute kidney
injury—pathophysiological basis and clinical performance. Acta Physiol (Oxf). 2017; 219(3):554–72.
Epub 2016/07/31. https://doi.org/10.1111/apha.12764 PMID: 27474473.
24. Mae S, Shono A, Shiota F, Yasuno T, Kajiwara M, Gotoda-Nishimura N, et al. Monitoring and robust
induction of nephrogenic intermediate mesoderm from human pluripotent stem cells. Nat Commun.
2013; 4:1367. Epub 2013/01/24. https://doi.org/10.1038/ncomms2378 PMID: 23340407.
25. Nishikawa M, Yanagawa N, Kojima N, Yuri S, Hauser PV, Jo OD, et al. Stepwise renal lineage differenti-
ation of mouse embryonic stem cells tracing in vivo development. Biochemical and Biophysical
Research Communications. 2012; 417(2):897–902. http://dx.doi.org/10.1016/j.bbrc.2011.12.071.
PMID: 22209845
26. Taguchi A, Kaku Y, Ohmori T, Sharmin S, Ogawa M, Sasaki H, et al. Redefining the In Vivo Origin of
Metanephric Nephron Progenitors Enables Generation of Complex Kidney Structures from Pluripotent
Stem Cells. Cell Stem Cell. 2014; 14(1):53–67. http://dx.doi.org/10.1016/j.stem.2013.11.010. PMID:
24332837
27. Xia Y, Nivet E, Sancho-Martinez I, Gallegos T, Suzuki K, Okamura D, et al. Directed differentiation of
human pluripotent cells to ureteric bud kidney progenitor-like cells. Nat Cell Biol. 2013; 15(12):1507–15.
http://www.nature.com/ncb/journal/v15/n12/abs/ncb2872.html#supplementary-information. https://doi.
org/10.1038/ncb2872 PMID: 24240476
28. Pera MF. Stem cells: The dark side of induced pluripotency. Nature. 2011; 471(7336):46–7. https://doi.
org/10.1038/471046a PMID: 21368819
29. Dontu G, Abdallah WM, Foley JM, Jackson KW, Clarke MF, Kawamura MJ, et al. In vitro propagation
and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev. 2003; 17(10):
1253–70. Epub 2003/05/21. https://doi.org/10.1101/gad.1061803 PMID: 12756227.
30. Kale S, Biermann S, Edwards C, Tarnowski C, Morris M, Long MW. Three-dimensional cellular develop-
ment is essential for ex vivo formation of human bone. Nat Biotechnol. 2000; 18(9):954–8. Epub 2000/
09/06. https://doi.org/10.1038/79439 PMID: 10973215.
31. Ootani A, Li X, Sangiorgi E, Ho QT, Ueno H, Toda S, et al. Sustained in vitro intestinal epithelial culture
within a Wnt-dependent stem cell niche. Nat Med. 2009; 15(6):701–6. Epub 2009/04/29. https://doi.org/
10.1038/nm.1951 PMID: 19398967.
32. Sato T, Vries RG, Snippert HJ, van de Wetering M, Barker N, Stange DE, et al. Single Lgr5 stem cells
build crypt-villus structures in vitro without a mesenchymal niche. Nature. 2009; 459(7244):262–5.
Epub 2009/03/31. https://doi.org/10.1038/nature07935 PMID: 19329995.
33. Barker N, Huch M, Kujala P, van de Wetering M, Snippert HJ, van Es JH, et al. Lgr5(+ve) stem cells
drive self-renewal in the stomach and build long-lived gastric units in vitro. Cell Stem Cell. 2010; 6(1):
25–36. Epub 2010/01/21. https://doi.org/10.1016/j.stem.2009.11.013 PMID: 20085740.
34. Jung P, Sato T, Merlos-Suarez A, Barriga FM, Iglesias M, Rossell D, et al. Isolation and in vitro expan-
sion of human colonic stem cells. Nat Med. 2011; 17(10):1225–7. Epub 2011/09/06. https://doi.org/10.
1038/nm.2470 PMID: 21892181.
35. Sato T, Stange DE, Ferrante M, Vries RG, Van Es JH, Van den Brink S, et al. Long-term expansion of
epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett’s epithelium. Gastroen-
terology. 2011; 141(5):1762–72. Epub 2011/09/06. https://doi.org/10.1053/j.gastro.2011.07.050 PMID:
21889923.
Kidney organotypic culture
PLOS ONE | https://doi.org/10.1371/journal.pone.0206447 October 31, 2018 12 / 13
36. Huch M, Dorrell C, Boj SF, van Es JH, Li VS, van de Wetering M, et al. In vitro expansion of single Lgr5+
liver stem cells induced by Wnt-driven regeneration. Nature. 2013; 494(7436):247–50. Epub 2013/01/
29. https://doi.org/10.1038/nature11826 PMID: 23354049.
37. Huch M, Gehart H, van Boxtel R, Hamer K, Blokzijl F, Verstegen Monique MA, et al. Long-Term Culture
of Genome-Stable Bipotent Stem Cells from Adult Human Liver. Cell. 2015; 160(1–2):299–312. http://
dx.doi.org/10.1016/j.cell.2014.11.050. PMID: 25533785
38. Boj Sylvia F, Hwang C-I, Baker Lindsey A, Chio Iok In C, Engle Dannielle D, Corbo V, et al. Organoid
Models of Human and Mouse Ductal Pancreatic Cancer. Cell. 2015; 160(1–2):324–38. http://dx.doi.org/
10.1016/j.cell.2014.12.021. PMID: 25557080
39. Lee JH, Bhang DH, Beede A, Huang TL, Stripp BR, Bloch KD, et al. Lung stem cell differentiation in
mice directed by endothelial cells via a BMP4-NFATc1-thrombospondin-1 axis. Cell. 2014; 156(3):
440–55. Epub 2014/02/04. https://doi.org/10.1016/j.cell.2013.12.039 PMID: 24485453.
40. Gao D, Vela I, Sboner A, Iaquinta PJ, Karthaus WR, Gopalan A, et al. Organoid cultures derived from
patients with advanced prostate cancer. Cell. 2014; 159(1):176–87. Epub 2014/09/10. https://doi.org/
10.1016/j.cell.2014.08.016 PMID: 25201530.
41. Karthaus WR, Iaquinta PJ, Drost J, Gracanin A, van Boxtel R, Wongvipat J, et al. Identification of multi-
potent luminal progenitor cells in human prostate organoid cultures. Cell. 2014; 159(1):163–75. Epub
2014/09/10. https://doi.org/10.1016/j.cell.2014.08.017 PMID: 25201529.
42. Nanduri LS, Baanstra M, Faber H, Rocchi C, Zwart E, de Haan G, et al. Purification and ex vivo expan-
sion of fully functional salivary gland stem cells. Stem Cell Reports. 2014; 3(6):957–64. Epub 2014/12/
03. https://doi.org/10.1016/j.stemcr.2014.09.015 PMID: 25448065.
43. Hisha H, Tanaka T, Kanno S, Tokuyama Y, Komai Y, Ohe S, et al. Establishment of a novel lingual
organoid culture system: generation of organoids having mature keratinized epithelium from adult epi-
thelial stem cells. Sci Rep. 2013; 3:3224. Epub 2013/11/16. https://doi.org/10.1038/srep03224 PMID:
24232854.
44. Huch M, Koo BK. Modeling mouse and human development using organoid cultures. Development.
2015; 142(18):3113–25. Epub 2015/09/24. https://doi.org/10.1242/dev.118570 PMID: 26395140.
45. Valentich JD, Tchao R, Leighton J. Hemicyst formation stimulated by cyclic AMP in dog kidney cell line
MDCK. J Cell Physiol. 1979; 100(2):291–304. Epub 1979/08/01. https://doi.org/10.1002/jcp.
1041000210 PMID: 229113.
46. Lopez-Novoa JM, Quiros Y, Vicente L, Morales AI, Lopez-Hernandez FJ. New insights into the mecha-
nism of aminoglycoside nephrotoxicity: an integrative point of view. Kidney International. 2011; 79(1):
33–45. http://dx.doi.org/10.1038/ki.2010.337. PMID: 20861826
47. Pabla N, Dong Z. Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney Int. 2008;
73(9):994–1007. Epub 2008/02/15. https://doi.org/10.1038/sj.ki.5002786 PMID: 18272962.
48. Freedman BS, Brooks CR, Lam AQ, Fu H, Morizane R, Agrawal V, et al. Modelling kidney disease with
CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids. Nat Commun.
2015; 6:8715. Epub 2015/10/27. https://doi.org/10.1038/ncomms9715 PMID: 26493500.
49. Hirsch HH, Brennan DC, Drachenberg CB, Ginevri F, Gordon J, Limaye AP, et al. Polyomavirus-associ-
ated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplan-
tation. 2005; 79(10):1277–86. Epub 2005/05/25. PMID: 15912088.
50. Yamanaka K, Oka K, Nakazawa S, Hirai T, Kishikawa H, Nishimura K, et al. Immunohistochemical fea-
tures of BK virus nephropathy in renal transplant recipients. Clin Transplant. 2012; 26 Suppl 24:20–4.
Epub 2012/07/07. https://doi.org/10.1111/j.1399-0012.2012.01636.x PMID: 22747471.
Kidney organotypic culture
PLOS ONE | https://doi.org/10.1371/journal.pone.0206447 October 31, 2018 13 / 13
